跳至主要内容
临床试验/NCT07166146
NCT07166146招募中不适用

Timing and Outcomes of Recovery After intraCerebral Hemorrhage

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年6月4日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Functional Outcome

研究概览

简要总结

The TORCH registry is a prospective, observational cohort study, which will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH. By leveraging a wide array of surgical interventions - including endoscopic surgery, minimally invasive surgery combined with urokinase, and craniotomy - the TORCH registry intends to provide a granular view of early hematoma evacuation surgical interventions and their impact on patient recovery and quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject Age is ≥18 to ≤80 years
  • Subject with a Head CT/CTA that demonstrates an acute, spontaneous, primary, supratentorial ICH, assessed via standard of care techniques
  • Subject recieving a surgery intervention
  • Subject has a NIHSS score ≥ 6 or GCS score 5≤GCS≤15
  • Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 1

排除标准

  • Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma)
  • Pre-stroke life expectancy < 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure [NYHA: III-IV], severe chronic obstructive pulmonary disease [III-IV], chronic kidney disease requiring hemodialysis)
  • Patients with platelet count < 100,000, INR > 1.4, or an elevated PT or APTT (reversal of coumadin is permitted but the patient must not require coumadin during the acute hospitalization). Irreversible coagulopathy either due to medical condition or prior to randomization
  • Pregnant (positive pregnancy test) or lactating females (likelihood of altered coagulation function associated with the high estrogen/progesterone state)
  • Irreversibly impaired brainstem function (bilateral fixed, dilated pupils and extensor motor posturing), GCS less than or equal to 4

结局指标

主要结局

Functional Outcome

时间窗: 6 months after onset

modified Rankin Score (mRS) 0=no symptoms, 1=no significant disability, 2=slight disability, 3= moderate disability, 4=moderate severe disability, 5=severe disability, 6=death

次要结局

  • Functional Outcome(3 months after onset)
  • Safety - Procedure -Related Mortality(30 days after onset)
  • EQ-5D-5L(6 months after onset)
  • Functional Status in Daily Life(6 months after onset)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验